FDA approves Roche’s Gazyva to treat follicular lymphoma

The US Food and Drug Administration (FDA) has granted approval for Roche's approved Gazyva (obinutuzumab) plus bendamustine chemotherapy, followed by Gazyva alone as a new treatment for people with follicular lymphoma.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news